Search results
Results from the WOW.Com Content Network
Temsirolimus is a specific inhibitor of mTOR and interferes with the synthesis of proteins that regulate proliferation, growth, and survival of tumor cells. Though temsirolimus shows activity on its own, it is also known to be converted to sirolimus (rapamycin) in vivo; [4] therefore, its activity may be more attributed to its metabolite rather than the prodrug itself (despite claims to the ...
mTOR inhibitors are a class of drugs used to treat several human diseases, including cancer, autoimmune diseases, and neurodegeneration. They function by inhibiting the mammalian target of rapamycin (mTOR) (also known as the mechanistic target of rapamycin), which is a serine/threonine-specific protein kinase that belongs to the family of phosphatidylinositol-3 kinase (PI3K) related kinases ...
Description: English: Skeletal formula of temsirolimus (brand name Torisel) — an mTOR inhibitor. Created with ChemDoodle and Adobe Illustrator CC 2017. Date: 19 ...
Description: English: Skeletal formula of sirolimus (brand name Rapamune) and temsirolimus (brand name Torisel) — mTOR inhibitors. Created with ChemDoodle and ...
ATC code L04 Immunosuppressants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
This pharmacology -related article is a stub. You can help Wikipedia by expanding it.
Vismodegib, sold under the brand name Erivedge, is a medication used for the treatment of basal-cell carcinoma (BCC). [3] The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. [4]